Chronic Bronchitis

Chronic Bronchitis Treatment

Cellular Therapy for Patients with Chronic Bronchitis

The Lung Institute is proud to offer alternative treatment options for patients with chronic bronchitis, which is one of the most prominent conditions that make up chronic obstructive pulmonary disease (COPD). We understand that dealing with chronic bronchitis can often seem overwhelming to the person affected, and our caring staff is here to help. We provide alternative treatments for chronic bronchitis that have helped many people return to their favorite activities. Specifically, we offer cellular therapy, which can potentially slow the progression of lung disease and improve a patient’s quality of life.

Our minimally invasive cellular therapy options for patients with chronic bronchitis include:

  • Blood-Derived Therapy ­– The procedure involves deriving cells from a patient’s own blood. This relatively quick and simple procedure entails drawing blood, isolating the cells in our onsite lab and returning the cells to the patient’s body intravenously to promote the body’s natural healing processes.

Our procedure are performed in an outpatient setting over the course of two days. Our devoted medical staff works closely with patients living with chronic bronchitis to develop an optimal treatment plan that meets their specific needs. More than 80 percent of patients report seeing improvement in their quality of life following treatment at the Lung Institute, the only cellular therapy clinic in the world focusing exclusively on treating lung disease.

To learn more about our cellular therapy options available to chronic bronchitis patients, contact the Lung Institute today at (800) 729-3065. Our caring team is ready to discuss how cellular therapy could help you get back to enjoying life.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.